A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1742-2094
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson’s disease ; volume:19 ; number:1 ; day:22 ; month:5 ; year:2022 ; pages:1-21 ; date:12.2022
Journal of neuroinflammation ; 19, Heft 1 (22.5.2022), 1-21, 12.2022

Creator
Lu, Jia
Wang, Chenfei
Cheng, Xin
Wang, Ruizhi
Yan, Xuehan
He, Pengju
Chen, Hongzhuan
Yu, Zhihua
Contributor
SpringerLink (Online service)

DOI
10.1186/s12974-022-02484-0
URN
urn:nbn:de:101:1-2022072600321364107500
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Lu, Jia
  • Wang, Chenfei
  • Cheng, Xin
  • Wang, Ruizhi
  • Yan, Xuehan
  • He, Pengju
  • Chen, Hongzhuan
  • Yu, Zhihua
  • SpringerLink (Online service)

Other Objects (12)

Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein

Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein

Parkinson’s disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype

Parkinson’s disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype

Models of α-synuclein aggregation in Parkinson’s disease

Models of α-synuclein aggregation in Parkinson’s disease

Microglial activation in Parkinson’s disease using [18F]-FEPPA

Microglial activation in Parkinson’s disease using [18F]-FEPPA

Dermal α-synuclein oligomers and aggregates in Parkinson’s disease

Dermal α-synuclein oligomers and aggregates in Parkinson’s disease

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

Initiation and progression of α-synuclein pathology in Parkinson’s disease

Initiation and progression of α-synuclein pathology in Parkinson’s disease

Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease

Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease

Retinal α-synuclein deposits in Parkinson’s disease patients and animal models

Retinal α-synuclein deposits in Parkinson’s disease patients and animal models

Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity

Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity

Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease

Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease

Related objects